These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12000972)

  • 1. Peroxisome proliferator-activated receptor ligands as antiatherogenic agents: panacea or another Pandora's box?
    Molavi B; Rasouli N; Mehta JL
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):1-8. PubMed ID: 12000972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C; Fruchart JC; Staels B
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of vascular inflammation by PPARs.
    Tham DM; Wang YX; Rutledge JC
    Drug News Perspect; 2003 Mar; 16(2):109-16. PubMed ID: 12792672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors and the cardiovascular system.
    Chen YE; Fu M; Zhang J; Zhu X; Lin Y; Akinbami MA; Song Q
    Vitam Horm; 2003; 66():157-88. PubMed ID: 12852255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension.
    Schiffrin EL; Amiri F; Benkirane K; Iglarz M; Diep QN
    Hypertension; 2003 Oct; 42(4):664-8. PubMed ID: 12874098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.
    Hsueh WA; Bruemmer D
    Hypertension; 2004 Feb; 43(2):297-305. PubMed ID: 14732733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors in endothelial cell biology.
    Plutzky J
    Curr Opin Lipidol; 2001 Oct; 12(5):511-8. PubMed ID: 11561170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.